MacroGenics | MGNX - Action





Action Changement Date
AbbVie USD 5.13B 78M 2026-06
Amgen USD 6.22B 34M 2026-06
AstraZeneca USD 6.93B 362M 2026-06
Biogen USD 2.38B 435.3M 2026-06
Bristol-Myers Squibb USD 2.74B 19M 2026-06
Daiichi Sankyo JPY 692.38B 83.83B 2026-03
Eli Lilly USD 16.79B 2.26B 2026-06
Genmab DKK 21M 8M 2026-03
Geron USD 123.6M 9.68M 2026-06
Gilead Sciences USD 1.91B 140M 2026-03
J&J USD 15.14B 561M 2026-06
Karyopharm Therapeutics USD 4.04M 72K 2025-12
MacroGenics USD 9.5M 1.59M 2026-03
Merck USD 6.21B 272M 2026-06
Pfizer USD 9.94B 722M 2026-06
Puma Biotechnology USD 9.48M 885K 2025-09
Regeneron Pharmaceuticals USD 3.08B 19.3M 2026-06
Roche Holding CHF 7.6B 9M 2025-06